Cargando…

Boosting Wnt activity during colorectal cancer progression through selective hypermethylation of Wnt signaling antagonists

BACKGROUND: There is emerging evidence that Wnt pathway activity may increase during the progression from colorectal adenoma to carcinoma and that this increase is potentially an important step towards the invasive stage. Here, we investigated whether epigenetic silencing of Wnt antagonists is the b...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva, Ana-Luisa, Dawson, Sarah N, Arends, Mark J, Guttula, Kiran, Hall, Nigel, Cameron, Ewen A, Huang, Tim H-M, Brenton, James D, Tavaré, Simon, Bienz, Mariann, Ibrahim, Ashraf EK
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265460/
https://www.ncbi.nlm.nih.gov/pubmed/25432628
http://dx.doi.org/10.1186/1471-2407-14-891
_version_ 1782348894800183296
author Silva, Ana-Luisa
Dawson, Sarah N
Arends, Mark J
Guttula, Kiran
Hall, Nigel
Cameron, Ewen A
Huang, Tim H-M
Brenton, James D
Tavaré, Simon
Bienz, Mariann
Ibrahim, Ashraf EK
author_facet Silva, Ana-Luisa
Dawson, Sarah N
Arends, Mark J
Guttula, Kiran
Hall, Nigel
Cameron, Ewen A
Huang, Tim H-M
Brenton, James D
Tavaré, Simon
Bienz, Mariann
Ibrahim, Ashraf EK
author_sort Silva, Ana-Luisa
collection PubMed
description BACKGROUND: There is emerging evidence that Wnt pathway activity may increase during the progression from colorectal adenoma to carcinoma and that this increase is potentially an important step towards the invasive stage. Here, we investigated whether epigenetic silencing of Wnt antagonists is the biological driver for this increased Wnt activity in human tissues and how these methylation changes correlate with MSI (Microsatelite Instability) and CIMP (CpG Island Methylator Phenotype) statuses as well as known mutations in genes driving colorectal neoplasia. METHODS: We conducted a systematic analysis by pyrosequencing, to determine the promoter methylation of CpG islands associated with 17 Wnt signaling component genes. Methylation levels were correlated with MSI and CIMP statuses and known mutations within the APC, BRAF and KRAS genes in 264 matched samples representing the progression from normal to pre-invasive adenoma to colorectal carcinoma. RESULTS: We discovered widespread hypermethylation of the Wnt antagonists SFRP1, SFRP2, SFRP5, DKK2, WIF1 and SOX17 in the transition from normal to adenoma with only the Wnt antagonists SFRP1, SFRP2, DKK2 and WIF1 showing further significant increase in methylation from adenoma to carcinoma. We show this to be accompanied by loss of expression of these Wnt antagonists, and by an increase in nuclear Wnt pathway activity. Mixed effects models revealed that mutations in APC, BRAF and KRAS occur at the transition from normal to adenoma stages whilst the hypermethylation of the Wnt antagonists continued to accumulate during the transitions from adenoma to carcinoma stages. CONCLUSION: Our study provides strong evidence for a correlation between progressive hypermethylation and silencing of several Wnt antagonists with stepping-up in Wnt pathway activity beyond the APC loss associated tumour-initiating Wnt signalling levels. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2407-14-891) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4265460
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42654602014-12-15 Boosting Wnt activity during colorectal cancer progression through selective hypermethylation of Wnt signaling antagonists Silva, Ana-Luisa Dawson, Sarah N Arends, Mark J Guttula, Kiran Hall, Nigel Cameron, Ewen A Huang, Tim H-M Brenton, James D Tavaré, Simon Bienz, Mariann Ibrahim, Ashraf EK BMC Cancer Research Article BACKGROUND: There is emerging evidence that Wnt pathway activity may increase during the progression from colorectal adenoma to carcinoma and that this increase is potentially an important step towards the invasive stage. Here, we investigated whether epigenetic silencing of Wnt antagonists is the biological driver for this increased Wnt activity in human tissues and how these methylation changes correlate with MSI (Microsatelite Instability) and CIMP (CpG Island Methylator Phenotype) statuses as well as known mutations in genes driving colorectal neoplasia. METHODS: We conducted a systematic analysis by pyrosequencing, to determine the promoter methylation of CpG islands associated with 17 Wnt signaling component genes. Methylation levels were correlated with MSI and CIMP statuses and known mutations within the APC, BRAF and KRAS genes in 264 matched samples representing the progression from normal to pre-invasive adenoma to colorectal carcinoma. RESULTS: We discovered widespread hypermethylation of the Wnt antagonists SFRP1, SFRP2, SFRP5, DKK2, WIF1 and SOX17 in the transition from normal to adenoma with only the Wnt antagonists SFRP1, SFRP2, DKK2 and WIF1 showing further significant increase in methylation from adenoma to carcinoma. We show this to be accompanied by loss of expression of these Wnt antagonists, and by an increase in nuclear Wnt pathway activity. Mixed effects models revealed that mutations in APC, BRAF and KRAS occur at the transition from normal to adenoma stages whilst the hypermethylation of the Wnt antagonists continued to accumulate during the transitions from adenoma to carcinoma stages. CONCLUSION: Our study provides strong evidence for a correlation between progressive hypermethylation and silencing of several Wnt antagonists with stepping-up in Wnt pathway activity beyond the APC loss associated tumour-initiating Wnt signalling levels. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1471-2407-14-891) contains supplementary material, which is available to authorized users. BioMed Central 2014-11-29 /pmc/articles/PMC4265460/ /pubmed/25432628 http://dx.doi.org/10.1186/1471-2407-14-891 Text en © Silva et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Silva, Ana-Luisa
Dawson, Sarah N
Arends, Mark J
Guttula, Kiran
Hall, Nigel
Cameron, Ewen A
Huang, Tim H-M
Brenton, James D
Tavaré, Simon
Bienz, Mariann
Ibrahim, Ashraf EK
Boosting Wnt activity during colorectal cancer progression through selective hypermethylation of Wnt signaling antagonists
title Boosting Wnt activity during colorectal cancer progression through selective hypermethylation of Wnt signaling antagonists
title_full Boosting Wnt activity during colorectal cancer progression through selective hypermethylation of Wnt signaling antagonists
title_fullStr Boosting Wnt activity during colorectal cancer progression through selective hypermethylation of Wnt signaling antagonists
title_full_unstemmed Boosting Wnt activity during colorectal cancer progression through selective hypermethylation of Wnt signaling antagonists
title_short Boosting Wnt activity during colorectal cancer progression through selective hypermethylation of Wnt signaling antagonists
title_sort boosting wnt activity during colorectal cancer progression through selective hypermethylation of wnt signaling antagonists
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265460/
https://www.ncbi.nlm.nih.gov/pubmed/25432628
http://dx.doi.org/10.1186/1471-2407-14-891
work_keys_str_mv AT silvaanaluisa boostingwntactivityduringcolorectalcancerprogressionthroughselectivehypermethylationofwntsignalingantagonists
AT dawsonsarahn boostingwntactivityduringcolorectalcancerprogressionthroughselectivehypermethylationofwntsignalingantagonists
AT arendsmarkj boostingwntactivityduringcolorectalcancerprogressionthroughselectivehypermethylationofwntsignalingantagonists
AT guttulakiran boostingwntactivityduringcolorectalcancerprogressionthroughselectivehypermethylationofwntsignalingantagonists
AT hallnigel boostingwntactivityduringcolorectalcancerprogressionthroughselectivehypermethylationofwntsignalingantagonists
AT cameronewena boostingwntactivityduringcolorectalcancerprogressionthroughselectivehypermethylationofwntsignalingantagonists
AT huangtimhm boostingwntactivityduringcolorectalcancerprogressionthroughselectivehypermethylationofwntsignalingantagonists
AT brentonjamesd boostingwntactivityduringcolorectalcancerprogressionthroughselectivehypermethylationofwntsignalingantagonists
AT tavaresimon boostingwntactivityduringcolorectalcancerprogressionthroughselectivehypermethylationofwntsignalingantagonists
AT bienzmariann boostingwntactivityduringcolorectalcancerprogressionthroughselectivehypermethylationofwntsignalingantagonists
AT ibrahimashrafek boostingwntactivityduringcolorectalcancerprogressionthroughselectivehypermethylationofwntsignalingantagonists